PL1888584T3 - Tricykliczne związki oparte na 1,6-dihydro-1,3,5,6-tetraaza-as-indacenie i zawierające je kompozycje farmaceutyczne jako inhibitory aktywności enzymu IKK - Google Patents
Tricykliczne związki oparte na 1,6-dihydro-1,3,5,6-tetraaza-as-indacenie i zawierające je kompozycje farmaceutyczne jako inhibitory aktywności enzymu IKKInfo
- Publication number
- PL1888584T3 PL1888584T3 PL06759417T PL06759417T PL1888584T3 PL 1888584 T3 PL1888584 T3 PL 1888584T3 PL 06759417 T PL06759417 T PL 06759417T PL 06759417 T PL06759417 T PL 06759417T PL 1888584 T3 PL1888584 T3 PL 1888584T3
- Authority
- PL
- Poland
- Prior art keywords
- tetraaza
- indacene
- dihydro
- inhibitors
- pharmaceutical compositions
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title 1
- 108090000790 Enzymes Proteins 0.000 title 1
- PATOMBNPWNCUCQ-UHFFFAOYSA-N N1C=CC2=C1N=CC1=C2NC=N1 Chemical compound N1C=CC2=C1N=CC1=C2NC=N1 PATOMBNPWNCUCQ-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67969205P | 2005-05-10 | 2005-05-10 | |
| US11/430,215 US7737279B2 (en) | 2005-05-10 | 2006-05-08 | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
| PCT/US2006/017950 WO2006122137A1 (en) | 2005-05-10 | 2006-05-09 | 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
| EP06759417A EP1888584B1 (en) | 2005-05-10 | 2006-05-09 | 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1888584T3 true PL1888584T3 (pl) | 2010-09-30 |
Family
ID=36808856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06759417T PL1888584T3 (pl) | 2005-05-10 | 2006-05-09 | Tricykliczne związki oparte na 1,6-dihydro-1,3,5,6-tetraaza-as-indacenie i zawierające je kompozycje farmaceutyczne jako inhibitory aktywności enzymu IKK |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7737279B2 (pl) |
| EP (1) | EP1888584B1 (pl) |
| JP (1) | JP5047164B2 (pl) |
| AR (1) | AR053725A1 (pl) |
| AT (1) | ATE465162T1 (pl) |
| CY (1) | CY1110419T1 (pl) |
| DE (1) | DE602006013816D1 (pl) |
| DK (1) | DK1888584T3 (pl) |
| ES (1) | ES2342976T3 (pl) |
| PE (1) | PE20061424A1 (pl) |
| PL (1) | PL1888584T3 (pl) |
| PT (1) | PT1888584E (pl) |
| SI (1) | SI1888584T1 (pl) |
| TW (1) | TW200718422A (pl) |
| WO (1) | WO2006122137A1 (pl) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7737279B2 (en) * | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
| HUE028347T2 (en) | 2008-06-10 | 2016-12-28 | Abbvie Inc | Tricyclic compounds |
| DK2473510T3 (da) * | 2009-09-03 | 2014-10-20 | Bristol Myers Squibb Co | Jak-2-hæmmere og anvendelse heraf til behandling af myeloproliferativesygdomme og cancer |
| HUE033099T2 (en) * | 2009-12-01 | 2017-11-28 | Abbvie Inc | Novel tricyclic compounds |
| WO2011068899A1 (en) | 2009-12-01 | 2011-06-09 | Abbott Laboratories | Novel tricyclic compounds |
| KR20140015162A (ko) * | 2010-01-12 | 2014-02-06 | 에프. 호프만-라 로슈 아게 | 트라이사이클릭 헤테로사이클릭 화합물, 조성물 및 이의 사용 방법 |
| WO2011112687A2 (en) * | 2010-03-10 | 2011-09-15 | Kalypsys, Inc. | Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| PT2861566T (pt) | 2012-06-13 | 2017-02-08 | Hoffmann La Roche | Novos diazaspirocicloalcanos e azaspirocicloalcanos |
| AU2013322838B2 (en) * | 2012-09-25 | 2018-02-01 | F. Hoffmann-La Roche Ag | New bicyclic derivatives |
| AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
| US9518058B2 (en) | 2013-08-29 | 2016-12-13 | Bristol-Myers Squibb Company | Process for the preparation of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide |
| EP3061754A4 (en) | 2013-10-23 | 2017-03-22 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| AU2014356583B2 (en) | 2013-11-26 | 2019-02-28 | F. Hoffmann-La Roche Ag | New octahydro-cyclobuta (1,2-c;3,4-c')dipyrrol-2-yl |
| WO2015144609A1 (en) | 2014-03-26 | 2015-10-01 | F. Hoffmann-La Roche Ag | Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors |
| AU2015238537B2 (en) | 2014-03-26 | 2019-08-01 | F. Hoffmann-La Roche Ag | Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors |
| MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
| UA123362C2 (uk) | 2015-09-04 | 2021-03-24 | Ф. Хоффманн-Ля Рош Аг | Феноксиметильні похідні |
| CR20180057A (es) | 2015-09-24 | 2018-04-02 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de atx/ca. |
| CR20180072A (es) | 2015-09-24 | 2018-02-26 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores de atx |
| AU2016328535A1 (en) | 2015-09-24 | 2017-11-09 | F. Hoffmann-La Roche Ag | Bicyclic compounds as ATX inhibitors |
| KR20180053408A (ko) | 2015-09-24 | 2018-05-21 | 에프. 호프만-라 로슈 아게 | 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서의 신규한 이환형 화합물 |
| US11365198B2 (en) | 2015-10-16 | 2022-06-21 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11512092B2 (en) | 2015-10-16 | 2022-11-29 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US11524964B2 (en) | 2015-10-16 | 2022-12-13 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| US10550126B2 (en) | 2015-10-16 | 2020-02-04 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-A]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| CA3251507A1 (en) | 2015-10-16 | 2025-05-21 | Abbvie Inc | Use of a solid dosage form comprising (3s,4r)-3-ethyl-4-(3h-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide for treating rheumatoid arthritis |
| US11780848B2 (en) | 2015-10-16 | 2023-10-10 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof |
| US12365689B2 (en) | 2015-10-16 | 2025-07-22 | Abbvie Inc. | Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof |
| JP7562256B2 (ja) * | 2016-08-15 | 2024-10-07 | パデュー リサーチ ファウンデイション | ４位置換アミノイソキノリン誘導体 |
| ES2922379T3 (es) | 2016-12-16 | 2022-09-14 | Janssen Pharmaceutica Nv | Compuestos de imidazo[4,5,D]pirrolo[2,3,B]piridina como inhibidores de Janus quinasas |
| JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| SG11201908560SA (en) | 2017-03-16 | 2019-10-30 | Hoffmann La Roche | Heterocyclic compounds useful as dual atx/ca inhibitors |
| CN110382484B (zh) | 2017-03-16 | 2022-12-06 | 豪夫迈·罗氏有限公司 | 新的作为atx抑制剂的二环化合物 |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| BR112023004550A2 (pt) * | 2020-10-08 | 2023-05-02 | Unichem Lab Ltd | Compostos tricíclicos substituídos |
| WO2022090481A1 (en) | 2020-11-02 | 2022-05-05 | Boehringer Ingelheim International Gmbh | Substituted 1h-pyrazolo[4,3-c]pyridines and derivatives as egfr inhibitors |
| AU2022233254A1 (en) | 2021-03-11 | 2023-10-26 | Janssen Pharmaceutica Nv | Lorpucitinib for use in the treatment of jak mediated disorders |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU651569B2 (en) | 1990-01-11 | 1994-07-28 | Isis Pharmaceuticals, Inc. | Compositions and methods for detecting and modulating RNA activity and gene expression |
| CA2321559A1 (en) | 1998-02-26 | 1999-09-02 | Ortho-Mcneil Pharmaceutical, Inc. | Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| TWI271406B (en) * | 1999-12-13 | 2007-01-21 | Eisai Co Ltd | Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same |
| AU2001285401A1 (en) | 2000-08-07 | 2002-02-18 | Neurogen Corporation | Heterocyclic compounds as ligands of the GABAa receptor |
| WO2003084959A1 (en) | 2002-04-03 | 2003-10-16 | Bristol-Myers Squibb Company | Thiopene-based tricyclic compounds and pharmaceutical compositions comprising same |
| WO2004075846A2 (en) | 2003-02-25 | 2004-09-10 | Bristol-Myers Squibb Company | Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| US7176214B2 (en) | 2003-05-21 | 2007-02-13 | Bristol-Myers Squibb Company | Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| US7071333B2 (en) | 2003-07-30 | 2006-07-04 | Bristol-Myers Squibb Company | Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| WO2005018555A2 (en) * | 2003-08-14 | 2005-03-03 | 3M Innovative Properties Company | Lipid-modified immune response modifiers |
| GB0403635D0 (en) | 2004-02-18 | 2004-03-24 | Devgen Nv | Pyridinocarboxamides with improved activity as kinase inhibitors |
| WO2005105788A1 (en) | 2004-04-23 | 2005-11-10 | Takeda San Diego, Inc. | Indole derivatives and use thereof as kinase inhibitors |
| ATE538124T1 (de) | 2004-11-12 | 2012-01-15 | Bristol Myers Squibb Co | Imidazokondensierte tricyclische verbindungen auf thiazoloä4,5-büpyridin-basis und pharmazeutische zusammensetzungen damit |
| WO2006053166A1 (en) | 2004-11-12 | 2006-05-18 | Bristol-Myers Squibb Company | 8h-imidazo[4,5-d]thiazolo[4,5-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| US7737279B2 (en) * | 2005-05-10 | 2010-06-15 | Bristol-Myers Squibb Company | 1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same |
-
2006
- 2006-05-08 US US11/430,215 patent/US7737279B2/en active Active
- 2006-05-09 EP EP06759417A patent/EP1888584B1/en not_active Not-in-force
- 2006-05-09 PL PL06759417T patent/PL1888584T3/pl unknown
- 2006-05-09 DE DE602006013816T patent/DE602006013816D1/de active Active
- 2006-05-09 SI SI200630671T patent/SI1888584T1/sl unknown
- 2006-05-09 JP JP2008511281A patent/JP5047164B2/ja not_active Expired - Fee Related
- 2006-05-09 AT AT06759417T patent/ATE465162T1/de active
- 2006-05-09 DK DK06759417.6T patent/DK1888584T3/da active
- 2006-05-09 WO PCT/US2006/017950 patent/WO2006122137A1/en not_active Ceased
- 2006-05-09 ES ES06759417T patent/ES2342976T3/es active Active
- 2006-05-09 PT PT06759417T patent/PT1888584E/pt unknown
- 2006-05-10 AR ARP060101882A patent/AR053725A1/es not_active Application Discontinuation
- 2006-05-10 PE PE2006000492A patent/PE20061424A1/es not_active Application Discontinuation
- 2006-05-10 TW TW095116493A patent/TW200718422A/zh unknown
-
2010
- 2010-04-23 US US12/765,932 patent/US8268855B2/en active Active
- 2010-07-19 CY CY20101100670T patent/CY1110419T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK1888584T3 (da) | 2010-08-09 |
| EP1888584B1 (en) | 2010-04-21 |
| US8268855B2 (en) | 2012-09-18 |
| WO2006122137A1 (en) | 2006-11-16 |
| US20060270654A1 (en) | 2006-11-30 |
| AR053725A1 (es) | 2007-05-16 |
| PT1888584E (pt) | 2010-06-22 |
| JP2008540547A (ja) | 2008-11-20 |
| DE602006013816D1 (de) | 2010-06-02 |
| ATE465162T1 (de) | 2010-05-15 |
| SI1888584T1 (sl) | 2010-07-30 |
| PE20061424A1 (es) | 2006-12-17 |
| EP1888584A1 (en) | 2008-02-20 |
| JP5047164B2 (ja) | 2012-10-10 |
| ES2342976T3 (es) | 2010-07-20 |
| CY1110419T1 (el) | 2015-04-29 |
| US20100210629A1 (en) | 2010-08-19 |
| TW200718422A (en) | 2007-05-16 |
| US7737279B2 (en) | 2010-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1888584T3 (pl) | Tricykliczne związki oparte na 1,6-dihydro-1,3,5,6-tetraaza-as-indacenie i zawierające je kompozycje farmaceutyczne jako inhibitory aktywności enzymu IKK | |
| WO2007136592A3 (en) | 2-0x0-l,2-dihydr0quin0line derivatives, compositions, and uses thereof as antiproliferative agents | |
| IL236013A0 (en) | Adamantyl acetamide derivatives as 11-beta-hydroxysteroid dehydrogenase type 1 enzyme inhibitors | |
| IL179837A0 (en) | Cyclic and heterocyclic compounds having anti-bacterial activity and pharmaceutical compositions containing the same | |
| IL182527A0 (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
| IL180946A0 (en) | 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof | |
| IL191141A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL186665A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| IL187434A0 (en) | Heterocyclic compounds and pharmaceutical compositions containing the same | |
| MY147949A (en) | Hydrogenated benzo[c]thiophene derivatives as immunomodulators | |
| IL181271A0 (en) | Triazolophthalazine derivatives and pharmaceutical compositions containing the same | |
| AU2008203254A1 (en) | Compositions of phosphodiesterase type IV inhibitors | |
| ZA200705474B (en) | Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme | |
| EP1954685A4 (en) | FUROXANE COMPOUNDS, COMPOSITIONS AND METHODS OF USE | |
| IL177496A0 (en) | Amido-substituted hydroxy -6-phenylphenanthridine derivatives and pharmaceutical compositions containing the same | |
| WO2005054244A3 (en) | Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain | |
| WO2007139833A3 (en) | Imidazoazephinone compounds | |
| IL184976A (en) | Pharmaceuticals containing tricyclic compounds and their uses | |
| HUE031355T2 (hu) | Vízben nem oldódó aktív szerves vegyületek kompozíciói | |
| IL186606A0 (en) | Compositions and uses of amooranin compounds | |
| TW200621773A (en) | Bicyclononene derivatives | |
| IL198634A0 (en) | Novel compounds, pharmaceutical compositions containing same, and methods of use for same | |
| WO2006031929A3 (en) | Thiazolopyridine kinase inhibitors | |
| ZA200609946B (en) | Adamantyl-acetamide derivatives as inhibitor of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme | |
| IL177735A0 (en) | Combined pharmaceutical composition for the inhibition of the decline of cognitive functions |